- OVID Dashboard
- Financials
- Filings
- ETFs
- Insider
- Institutional
- Shorts
- News
- Patents
-
ARS Filing
Ovid Therapeutics (OVID) ARS2024 FY Annual report to shareholders
Filed: 24 Apr 24, 5:00pm
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.